Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics

MLA

Prabhakar Viswanathan, et al. “Low-Dose Rosiglitazone Exerts an Antiinflammatory Effect with an Increase in Adiponectin Independently of Free Fatty Acid Fall and Insulin Sensitization in Obese Type 2 Diabetics.” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, June 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d864dada351fa0ebac739c183ffc1cb0&authtype=sso&custid=ns315887.

APA

Prabhakar Viswanathan, Paresh Dandona, Husam Ghanim, Ahmad Aljada, Sandeep Dhindsa, & Ajay Chaudhuri. (2006). Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. The Journal of Clinical Endocrinology and Metabolism, 91(9).

Chicago

Prabhakar Viswanathan, Paresh Dandona, Husam Ghanim, Ahmad Aljada, Sandeep Dhindsa, and Ajay Chaudhuri. 2006. “Low-Dose Rosiglitazone Exerts an Antiinflammatory Effect with an Increase in Adiponectin Independently of Free Fatty Acid Fall and Insulin Sensitization in Obese Type 2 Diabetics.” The Journal of Clinical Endocrinology and Metabolism 91 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d864dada351fa0ebac739c183ffc1cb0&authtype=sso&custid=ns315887.